Usop, Azhar D.
HRN: 22-96-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2023
CEFUROXIME 1.5GM (VIAL)
04/26/2023
05/03/2023
IV
1g
Q8H
Fracture, Closed, Complete, D/3rd, Left Radius
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes